Emis says trading in line as eyes new acquisition opportunities

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Healthcare and solutions provider EMIS Group PLC on Thursday said it is trading in line with board expectations and is seeking new acquisition opportunities.

The Leeds-based company, which makes software used by healthcare providers, gave the update ahead of its annual general meeting.

‘The group continues to have leading positions in specialist markets, benefits from high levels of recurring revenue and remains in a strong financial position, with a robust pipeline of potential new business, investment and acquisition opportunities for 2022 and beyond,’ Emis said.

Their two acquisitions completed in the year so far, Edenbridge Healthcare Ltd and FourteenFish, are performing well, Emis said.

Chief Executive Officer Andy Thorburn said: ‘The board is pleased to report a good start to trading in 2022 and believes the group continues to be very well placed to deliver greater insight, efficiency and integration in healthcare for the benefit of our customers across the NHS and private sectors.’

Emis is set to continue investing in its technology and cloud refresh strategy, delivering greater efficiencies, it said.

Back in March, Emis posted pretax profit of £36.1 million for 2021, down 2.2% from £36.9 million in 2020. Revenue increased by 5.5% to £168.2 million from £159.5 million.

Emis shares were up 2.9% at 1,368.00 pence each on Thursday afternoon in London.

Copyright 2022 Alliance News Limited. All Rights Reserved.